Astonea Labs Ltd
₹0.00▲ +0.00 (+0.00%)
544409·NSE·Healthcare
Market Cap
275.10 Cr
PE Ratio
60.90
Volume
—
Day High - Low
—
52W High-Low
301.30 - 118.00
₹0.00▲ +0.00 (+0.00%)
Market Cap275.10 Cr
PE Ratio60.90
Volume—
Day High - Low—
52W High-Low301.30 - 118.00
Astonea Labs Ltd (544409): company summary
Astonea Labs Ltd (544409) is a micro-cap Healthcare company valued at ₹275 crore operating in Pharmaceuticals on the NSE and BSE.
Astonea Labs Ltd (544409) is a micro-cap Healthcare company valued at ₹275 crore operating in Pharmaceuticals on the NSE and BSE.
- Financial performance
- Revenue has been growing strongly at 30.1% a year over three years; profit grew 57.8% a year, ahead of revenue — margins are expanding. Return on equity is 12.0%.
- Valuation multiples
- The stock trades at 60.9 times earnings, a premium to the Healthcare median of 32.5, 4.82 times book value.
Generated from DocStoX data. This is a factual summary, not a rating or a recommendation. Informational only, not investment advice. Consult a SEBI-registered adviser before investing.
Not currently trading — we have seen no trades on NSE or BSE recently. It may be suspended, delisted, or renamed after a corporate action. Not a live price.
DocStoX Score
4.2/10
Weak
Fair Value
Sign in to see
ROE
12.00%
Average
P/E
60.90x
Expensive
Debt / Equity
0.74
Moderate
Industry
Healthcare
Pharmaceuticals
Overall View
Mixed
Price performance
52W₹118.00
₹301.30
DocStoX take
Supported by growth (10.0), but held back by valuation (0.0). Growth looks strong at 10.0, but that is offset by valuation at 0.0. We are calling it Mixed rather than resolving the conflict for you. Scored on 4 of 5 measures.
DocStoX score
Medium confidence4.2
/10
Weak
Quality
Modest
ROE 12.0%
Valuation
Expensive
P/E 60.9×
Growth
Strong
Revenue +30.1% 3Y CAGR
Risk
Elevated
D/E 0.74
Momentum
No data
No technical indicators
Scored on 4 of 5 measures — the rest have no data for this company.
At a glance
Market Cap
₹275 Cr
52W High / Low
₹301 / ₹118
Dividend Yield
0.00%
Promoter Holding
72.30%
EPS (TTM)
₹6.93
Book Value
₹54.35
Key highlights
- Profit compounding 58% a year
- Revenue compounding 30% a year
- Valuation is weak (0.0/10)
- Expensive at 61× earnings
2 Positives3 Watchouts
Growth
Financials
Technicals
Peers
News
Forecasts
About the company
More data
Filings, corporate actions and ownership detail — opened on demand.
More Healthcare stocks · Pharmaceuticals
Explore Astonea Labs Ltd’s valuation
Free deep-dive tools · no sign-up
Fair ValueOur fair-value estimate, upside, and Bear/Base/Bull scenarios.Intrinsic ValueGraham & earnings-power intrinsic value with margin of safety.DCFDiscounted cash flow — free cash flow, growth, value per share.ValuationP/E, P/B, earnings yield and the full multiples picture.Financial RatiosProfitability, leverage and efficiency ratios at a glance.PeersHow it stacks up against its closest listed competitors.
Astonea Labs Ltd peers in Healthcare
Other Healthcare stocks on the NSE & BSE. See the full Healthcare sector list.
Related tools & concepts
Value Astonea Labs Ltd with the ratios and calculators DocStoX uses in its analysis.
P/E RatioPrice to earningsReturn on Equity (ROE)ProfitabilityROCECapital efficiencyDebt to EquityLeverageP/B RatioPrice to bookNet Profit MarginBottom-line efficiencyDCF / Intrinsic ValueEstimate fair valueCAGR CalculatorAnnualised returnDividend YieldIncome on pricePosition SizeRisk-based sizingBrokerage CalculatorCharges on a tradeSIP CalculatorSystematic investing